Search PubMed⌕ Search

Biomedical subjects

B Kaiser

Publications and source records attributed to B Kaiser.

85 records · Page 5Linked to original sources
PubMed1980

Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin.

A series of new specific inhibitors of thrombin, cyclic amides of N alpha-arylsulfonyl-amidinophenylalanine, was studied for anticoagulant action in vitro and in vivo. The inhibitors showed strong anticoagulant effects in vitro. The time course of the anticoagulant effect of the inhibitors in rabbits and rats was monitored using plasma thrombin time determinations. In rats, the inhibitors prevented the formation of experimental venous thrombi and of thrombin-induced microthrombosis. The new derivatives of benzamidine presented may be useful as immediately acting anticoagulants.

Amidines↗
PubMed1980

Problems of an optimum digitalis therapy.

In 25 digitalized patients with ischaemic heart disease who had survived a myocardial infarction for 2 to 4 weeks, the systolic time intervals (STI) and changes of glycoside plasma level were measured before and up to 5 hrs after oral intake of a maintenance dose of digitoxin (n = 18) or of digoxin (n = 7). Between the changes of STI and the increase in digitoxon and digoxin plasma level no significant correlations were found. Therefore it is concluded that neither shortening of STI during the test period nor PEP/LVET are reliable criteria of individualizing and optimizing the therapy with cardioactive glycosides.

Adult↗
PubMed1978

[Pharmacological effect of pentacyanonitrosylferrate and similar complex compounds].

Comparative studies were performed on the spasmolytic and hypotensive effects of pentacyanoferrates with different ligands (NO, NO2, NOS, NH3, H2O) and of hexacyanoferrates and other nitrosyl compounds. Besides sodium nitroprusside, the nitro and thionitro complexes in equimolar doses were found to cause hypotension and relaxation of the aortic strip of rabbits contracted by adrenaline and spasmolytic effects on the contracted guinea pig ileum. The liberated nitrosyl cation or its secondary product, nitrous acid, is thought to be responsible for the pharmacodynamic effects of these complex compounds. This is in agreement with the fact that also other nitrosyl compounds (nitrosyl perchlorate, nitrosyl-bis(dimethylglyoximato)cobaltIII) and free undissociated nitrous acid produce transient spasmolytic effects. Pentacyanoaquoferrate and hexacyanoferrateIII exert, presumably because of the oxydation of sulfhydryl groups, spasmolytic effects in vitro. Accordingly, their effects are prevented in the presence of sulfhydryl compounds such as glutathion or dithioerythrit.

Animals↗
PubMed1976

[Peritoneoscopy with 2 optical devices: reduced risk - better diagnostic results (author's transl)].

Peritoneoscopy with 2 optical devices was performed in two cases; the technique of this procedure is described. The method allows inspection of areas, which cannot be seen during routine peritoneoscopy, especially of the anterior abdominal wall and of intraabdominal organs covered by adhesions. In addition, this method allows to find out, whether the anterior abdominal wall and vessels in it were injured by the troikart; the risk of the procedure is reduced thereby. Using a second optical device allows to visualize areas, which cannot be studied during routine peritoneoscopy because of intraabdominal adhesions. Thus better diagnostic results can be achieved with this method as compared to the routine technique.

Aged↗
PubMedDate not supplied

Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients.

This study documents a pharmacokinetic interaction between carbamazepine and cyclosporine (CsA) in pediatric renal transplant recipients. Noncompartmental steady-state CsA pharmacokinetics were determined in three pediatric renal transplant recipients who were receiving both CsA and carbamazepine as long-term therapy (carbamazepine group) and in three matched renal transplant subjects who were not receiving carbamazepine (control group). Even though the mean daily dosage of CsA was consistently higher in the carbamazepine group than in the control group (16.2 mg/kg/24 hrs vs 10.8 mg/kg/24 hrs, respectively), the predose trough CsA blood concentrations were significantly lower in the carbamazepine group (57 ng/ml vs 162 ng/ml, respectively; p = 0.0023). Mean average steady-state blood concentrations of CsA (Cav) per mg of CsA administered were less than 50% in the carbamazepine group compared with the control group. This reflects either an induction of CsA hepatic metabolism or a reduced systemic bioavailability (possible induction of pre-hepatic metabolism) by concurrent use of carbamazepine.

Carbamazepine↗